Shridhar Pandya
Script error: No such module "Draft topics".
Script error: No such module "AfC topic".
 | The neutrality of this article is disputed. (January 2022) (Learn how and when to remove this template message) |
| Shridhar Pandya | |
|---|---|
 Image_of_dr._shridhar_pandya.jpg | |
| Born | 18 January 1984 Surat, India |
| 🏳️ Nationality | Indian |
| 🏫 Education | Jodhpur National University (PhD), AISSMS College of Pharmacy (M. Pharm.) |
| 💼 Occupation | Director at Gplife Healthcare Pvt. Ltd. India |
| 🌐 Website | Gplife |
Shridhar Pandya (born 18 January 1984) is a key Scientist and Managing Director at Gplife Healthcare Pvt. Ltd-India.[1] He has 40+ Research & Review articles in various national and international journals such as ResearchGate. Furthermore, He has 16 years experience in the Phytochemistry and Phyto Pharmaceutical research field.
Early life and education[edit]
He has a PhD in pharmaceutical science and technology from JNU. He was born in Surat city in the Indian state of Gujarat. He is the Managing Director at Gplife Healthcare Pvt. Ltd. India. He also has 40+ research and review articles in various national and international journals such as ResearchGate[2] and World Journal of Pharmaceutical Research.[citation needed] He has 16 years experience in the phytochemistry and phyto pharmaceutical research field.
Career[edit]
Shridhar Pandya has been engaged in botanical and phyto pharma research since 2007. In the IPR Portfolio of Gplife, 20+ patents have been provisionally submitted, and 30+ patents are under review for submission.[citation needed]
He also has an article published on a novel approach in gastro retentive drug delivery system, floating drug delivery system, on ResearchGate.[3]
He has developed an algorithm and statistical model of 300+ phytochemicals and their synergy effects to regenerate cells to solve chronic diseases at Gplife. Gplife has developed 40+ products, and other 50+ new products are under case study.
Team of Gplife has published more than 50+ research and Review articles in various National and International Journals.[4] He represented Gplife Healthcare Pvt. Ltd. at the 13th World Congress of Regenerative medicine & Stem Cell at Dalian, China.[5] Science of Gplife has been published in London, USA, Thailand, China and Singapore.
Online publications[edit]
- Improvement of Photostability in Formulation: A Review (Asian Journal of Chemistry Vol. 20, No. 7 (2008), 5095-5108)[6]
- Biocompatible polymer of waxes as pharmaceutical excipients. (Nov-Dec 2009) Pharma review. Pg. No 131-137
- A Novel approach in gastro retentive drug delivery system: Floating drug delivery system. International journal of pharmaceutical sciences and research 2010; 1(6): 7-18.[7]
- Compatible Polymer used as complexes in various drug delivery systems: β- Cyclodextrin. (Review). ( pharmainfo.net) Vol. 5 Issue 6-2007
- Statistically optimization of drug formulation using factorial design. (Review). (pharmainfo.net) Vol. 6 Issue 2- 2008
- Carbopol and its Applications in pharmaceutical dosage forms(Review). (pharmainfo.net) Vol. 6 Issue 2- 2008
- Various Polymer Use in Pharmaceutical Application And Polymer Coating (Review). ( pharmainfo.net) Vol. 5 Issue 6-2007
Research articles as a speaker[edit]
- Role of act 12 and act 13, a phytoconstituents complex as a potential therapy for management of Covid-19; a comprehensive study report[8][9]
- SARS-COV2 ANTIVIRAL TESTING REPORT OF ACT 12 AND 13: SHORT COMMUNICATION[10]
- Clinical trial of herbal supplement as an immunomodulator in adult Covid-19 positive patients.[11]
- Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid-19 patients.[12]
- Optimization Effect of Superdisintegrants and Subliming Agent on Orodispersible Tablet of Loratidine[13]
- EVALUATION OF ANTIOXIDANT ACTIVITY AND STANDARDIZATION OF ACT 12 AND ACT 13 FORMULATIONS[14]
- ROLE OF ACT 12 AND ACT 13, A PHYTOCONSTITUENTS COMPLEX AS A POTENTIAL PROPHYLAXIS FOR MANAGEMENT OF COVID 19: A COMPREHENSIVE CASE STUDY REPORT[15]
- Control chart: A statistical process control tool in pharmacy[16][17][18]
- DESIGN AND DEVELOPMENT OF SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM TO ENHANCE SOLUBILITY OF OLMESARTAN MEDOXOMIL[19][20]
- Improvement of photostability in Formulation: A Review[21][22]
- Formulation development of Olmesartan Medoxomil solid self microemulsifying drug delivery system[23]
- Beat diabetes with GPLIFE – Advanced diabetic support tablet[24]
References[edit]
- ↑ https://gplife.in/
- ↑ https://www.researchgate.net/publication/351796121_Brief_Review_on_Diabetes-A_Metabolic_Disease
- ↑ https://www.researchgate.net/publication/228556924_A_novel_approach_in_gastro_retentive_drug_delivery_system_Floating_drug_delivery_system
- ↑ "S. Pandya | Semantic Scholar". www.semanticscholar.org. Retrieved 2022-01-19.
- ↑ "The 13th World Congress of Regenerative Medicine & Stem Cell (RMSC-2019)". www.bitcongress.com. Retrieved 2022-01-19.
- ↑ "Free Article". asianjournalofchemistry.co.in. Retrieved 2022-01-12.
- ↑ Shah, Samip; Pandya, DrShridhar (2010-01-01). "A novel approach in gastro retentive drug delivery system: Floating drug delivery system". International Journal of Pharma Sciences and Research. 1.
- ↑ Pandya, Shridhar. "World Journal of Pharmaceutical Research" (PDF). World Journal of Pharmaceutical Research.
- ↑ Pandya, Dr Shridhar; Goti, Ghanshyam; Gajera, Dr K. M. "WJPR - Abstract". World Journal of Pharmaceutical Research.
- ↑ Pandya, Shridhar. "International Journal of Medical Science and Education" (PDF). International Journal of Medical Science and Education.
- ↑ Pandya, Shridhar. "International Clinical Trials Registry Platform". World Health Organization. Unknown parameter
|url-status=ignored (help) - ↑ Pandya, Shridhar. "Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patients". World Health Organization.
- ↑ Shivani Mehta, Dr. Shridhar Pandya (2020). "Optimization Effect of Superdisintegrants and Subliming Agent on Orodispersible Tablet of Lorantidine" (PDF). SRYAHWA Publications. 3: 5 – via Archives of Diabetes and Endocrine System.
- ↑ "EJPMR | ABSTRACT". www.ejpmr.com. Retrieved 2022-01-19.
- ↑ Pandya*, Shridhar Jitubhai; Savaliya, Chetan Himmatbhai. "WJPR - Abstract". World Journal of Pharmaceutical Research (in עברית). ISSN 2277-7105.
- ↑ ""Control chart: A statistical process control tool in pharmacy" on Publons". publons.com. Retrieved 2022-01-19.
- ↑ Shah, Samip; Shridhar, Pandya; Gohil, Dipti (2010). "Control chart : A statistical process control tool in pharmacy". Asian J Pharm. 4 (3): 184. doi:10.4103/0973-8398.72116.
- ↑ Shah, Samip; Shridhar, Pandya; Gohil, Dipti (2014-08-27). "Control chart: A statistical process control tool in pharmacy". Asian Journal of Pharmaceutics (AJP): Free Full Text Articles from Asian J Pharm. 4 (3). doi:10.22377/ajp.v4i3.144 (inactive 28 February 2022). ISSN 1998-409X.
- ↑ "Pharma Science Monitor". www.pharmasm.com. Retrieved 2022-01-19.
- ↑ "DESIGN AND DEVELOPMENT OF SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM TO ENHANCE SOLUBILITY OF OLMESARTAN MEDOXOMIL". scholar.google.co.in. Retrieved 2022-01-19.
- ↑ "Free Article". asianjournalofchemistry.co.in. Retrieved 2022-01-19.
- ↑ "Asian Journal of Chemistry ::". Retrieved 2022-01-19.
- ↑ "Formulation Development Of Olmesartan Medoxomil Solid Self Microemulsifying Drug Delivery System, IJAR - Indian Journal of Applied Research(IJAR), IJAR | World Wide Journals". www.worldwidejournals.com. Retrieved 2022-01-19.
- ↑ "Beat diabetes with GPLIFE - Advanced diabetic support tablet". scientific e-news. Retrieved 2022-01-19.
This article "Shridhar Pandya" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Shridhar Pandya. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
